|Titan Pharmaceuticals Inc.|
400 Oyster Point Boulevard
South San Francisco,
United States - Map
Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States. The company offers Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia. It is involved in developing Probuphine, an investigational subdermal implant for the treatment of opioid dependence. The Probuphine utilizes the companys novel, proprietary drug delivery technology, ProNeura, which is used in developing products for the treatment of other chronic conditions, such as Parkinsons disease. Titan Pharmaceuticals, Inc. was founded in 1992 and is based in South San Francisco, California.
|Dr. Marc Rubin M. D.,
Exec. Chairman and Member of Exec. Committee
|Mr. Sunil Bhonsle M.B.A.,
Principal Exec. Officer, Pres, Principal Financial Officer, Sec. and Director
| Brian Crowley ,
Principal Accounting Officer and VP of Fin.
|Dr. Katherine L. Beebe Ph.D.,
Exec. VP and Chief Devel. Officer
|Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|